List of Contributors.
Part 1 Investigating IBD in the 21st Century.
1 Capsule endoscopy: do we need it (Joel E D Mawdsley & Mark Appleyard).
2 Pathology reports – pitfalls for the unwary (Wilfred Weinstein).
3 Non-invasive diagnosis and assessment (Alex J Di Mambro, Ana Terlevich & Chris Probert).
4 What is the best way to image perianal Crohn’s disease (Vikram A Sahni & Alison McLean).
5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome (Mark Lust & William Connell).
6 Abnormal liver tests – what should we do about them (Richard Marley & Abid Suddle).
Part 2 Medical Treatment: Making the Most of What We’ve Got.
7 Is monitoring necessary (Rakesh Shah & Alastair Forbes).
8 Do they have a role in Crohn’s disease (Vikrant Sibartie & Brian Feagan).
9 Steroids in Crohn’s: are they obsolete (David Rampton).
Antibiotics for Crohn’s disease.
10 Antibiotics: which, when and for how long (Alex Kent & Jean-Frédéric Colombel).
11 Mycobacterium avium paratuberculosis in Crohn’s disease: player or spectator (Geoff Smith & Fergus Shanahan).
12 TPMT testing: is it essential (Azhar Ansari & Jeremy D Sanderson).
13 6-Mercaptopurine or azathioprine (Dermot McGovern & Simon Travis).
14 Thiopurines: how long should we use them for (Alexandra Daley & Marc Lémann).
15 Making the most of methotrexate (Emma Greig, John Keohane & Brian Feagan).
16 Cyclosporine: balancing risk and benefit (Helena Deeney & Barney Hawthorne).
17 Contraindications – absolute or relative (Rakesh Chaudhary & Subrata Ghosh).
18 How can we prevent tuberculosis (Sasha Beresford & David Rampton).
19 Dealing with infusion reactions (Gert Van Assche, Séverine Vermeire & Paul Rutgeerts).
20 Use in ulcerative colitis (Sreedhar Subramanian & Jonathan Rhodes).
21 Infliximab and surgery: health or hazard (David Rampton).
Nutritional therapy for Crohn’s disease.
22 Nutritional therapy for Crohn’s disease: is it for adults (Donald R Duerksen & Charles N Bernstein).
Part 3 Medical Treatment: What’s Round the Corner?.
23 Trials and tribulations – interpreting clinical trials in IBD (Elizabeth Carty & David Rampton).
24 Genetics – clinical and therapeutic applications (Mark Tremelling & Miles Parkes).
25 Probiotics – separating science from snakeoil (Fergus Shanahan & John Keohane).
26 Worms (David Grunkemeier & R Balfour Sartor).
27 Smoking and nicotine – poison for Crohn’s, potion for colitis (Brian Bressler & A Hillary Steinhart).
28 Heparin (Ailsa Hart & Stuart Bloom).
29 Leukocytapheresis: filtering out the facts (Peter Irving & David Rampton).
30 Appendectomy for ulcerative colitis – a therapeutic option (Richard Makins & Graham Radford-Smith).
31 Biologic treatments in IBD (Raymond D’Souza & James Lindsay).
32 Stem cell transplantation for IBD (Paul Fortun & Christopher Hawkey).
33 Complementary and alternative therapy – the way forward or a step back (Louise Langmead & David Rampton).
Part 4 Common Clinical Challenges: Beyond the Text Book.
34 Functional problems (Eamonn Quigley).
35 Psychological stress: something to worry about (Joel E D Mawdsley & David Rampton).
36 Drugs to avoid (Paul Collins & Jonathan Rhodes).
37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD (Ingvar Bjarnason & David Scott).
38 Iron replacement – is it safe and effective (Stefanie Kulnigg & Christoph Gasche).
39 Hepatitis B and C viruses – how do they affect management of IBD (Graham R Foster & Alick N S Nkhoma).
40 Pregnancy: what drugs can we use (Thea Thomas & Elspeth Alstead).
41 How to prevent growth failure in children (Jutta Köglmeier & Nick Croft).
42 Predicting outcomes in severe UC. .
43 Refractory proctitis (Anne Ballinger & Richard Makins).
44 CMV co-infection – does it matter (Daan Hommes).
45 Treatment of oral Crohn’s disease (Carlo Nunes, Michael Escudier & Jeremy D Sanderson).
46 Pathophysiologic approach to treatment of diarrhea in Crohn’s disease (Henry J Binder).
47 Short bowel (Jeremy Nightingale).
48 Management of internal fistulae (David Rampton).
49 What is indeterminate colitis (Garret Cullen & Diarmuid O’Donoghue).
50 Pouches for indeterminate colitis (Laura Hancock & Neil Mortensen).
51 Colitis-associated cancer: what’s the risk to your patients (Jayne Eaden).
52 What to do with dysplasia, DALMs, and adenomas (Matt Rutter).
Part 5 Managing IBD Outside the Gut.
53 Pyoderma gangrenosum (Ana Paula Cunha & Fernando Tavarela Veloso).
54 Arthritides – helping the joints without harming the gut (Horace Williams & Tim Orchard).
55 Prevention and treatment of osteoporosis (Richard Makins & Juliet Compston ).
56 Sclerosing cholangitis – what to do (Sue Cullen & Roger Chapman).
57 Thromboembolic disease: an under-recognized complication (Peter Irving & Fergus Shanahan).
58 Pulmonary manifestations: rare but real (Peter Irving).
Part 6 Are You Sure it’s IBD?.
59 Intestinal infections: mimics and precipitants of relapse (Sunil Samuel & Yashwant Mahida).
60 Microscopic colitis (Debbie Nathan & Peter Gibson).
61 Diverticular colitis (Linmarie Ludeman & Neil A Shepherd).
Part 7 The IBD Service: Time for a Rethink?.
62 Outpatient services – do doctors still have a role (Mark Kelly & Andrew Robinson).
63 Shared care: tactical team selection (Reshma C Rakshit & John Mayberry).
64 Databases – are they worth the bother (Stephen L Grainger).